Company / Cost of Revenue
Envista Holdings Cost of Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$1.2B
FY2025
5-year range
$1.1B / $1.2B
FY2021-FY2025
Trend
+8.3%
vs FY2024
Sector context
#43 of 107
Health Care
What the data says
At $1.2B, Envista Holdings's cost of revenue ranks #65 of 107 in the Health Care sector. Cost of Revenue has increased for 5 consecutive years, from $874M in FY2020 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +7.1%.
Increased from $1.1B to $1.2B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +4.1%
- 5-Year CAGR
- +7.1%
- 10-Year CAGR
- -
Sector benchmark
#65 of 107 in Health CareTop 60% of 107This company $1.2B Sector average $11.8B
▼
-89.5% below sector average
Key checks
Key Insights
- Envista Holdings's cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +7.1%, indicating consistent growth.
- In FY2025, cost of revenue increased 8.3% year-over-year.
- Ranks #43 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +8.3% |
| FY2024 | $1.1B | +1.1% |
| FY2023 | $1.1B | +2.9% |
| FY2022 | $1.1B | +1.1% |
| FY2021 | $1.1B | +23.8% |
| FY2020 | $874.3M | -6.6% |
| FY2019 | $935.6M | -24.7% |
| FY2018 | $1.2B | +4.5% |
| FY2017 | $1.2B | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026